# Agios Pharmaceuticals, Inc. (AGIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AGIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 65.49M | $ -199.81M | $ -178.21M | $ 31.17M | $ 1.03B |
| 2025 | $ 55.32M | $ -422.65M | $ -386.31M | $ 40.21M | $ 1.19B |
| 2024 | $ 38.36M | $ 708.14M | $ -411.52M | $ 56.99M | $ 1.54B |
| 2023 | $ 29.00M | $ -380.70M | $ -321.20M | $ 72.00M | $ 811.02M |
| 2022 | $ 15.91M | $ -258.95M | $ -351.17M | $ 85.66M | $ 1.10B |
| 2021 | $ 0 | $ -456.94M | $ -490.99M | $ 97.09M | $ 1.29B |
| 2020 | $ 258.86M | $ -417.05M | $ -388.38M | $ 105.20M | $ 399.50M |
| 2019 | $ 152.19M | $ -531.11M | $ -494.09M | $ 113.66M | $ 640.53M |
| 2018 | $ 124.66M | $ -457.00M | $ -411.27M | $ 0 | $ 687.54M |
| 2017 | $ 57.94M | $ -423.90M | $ -390.48M | $ 0 | $ 375.50M |
| 2016 | $ 96.16M | $ -273.06M | $ 39.41M | $ 0 | $ 358.59M |
| 2015 | $ 83.01M | $ -165.30M | $ -136.35M | $ 0 | $ 345.12M |
| 2014 | $ 92.35M | $ -75.60M | $ -87.00M | $ 0 | $ 424.37M |
| 2013 | $ 36.34M | $ -56.05M | $ -82.05M | $ 0 | $ 131.48M |
| 2012 | $ 36.25M | $ -29.02M | $ -73.66M | $ 0 | $ 43.90M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 10.22 |

## Other views

- [Metrics](https://sponda.capital/en/AGIO.md)
- [Charts](https://sponda.capital/en/AGIO/charts.md)
- [Compare](https://sponda.capital/en/AGIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.